What is the ticker symbol for Gain Therapeutics?

Gain Therapeutics trades under the ticker GANX on NASDAQ.

What sector does Gain Therapeutics operate in?

Gain Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GANX in a portfolio?

PortView shows GANX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Gain Therapeutics (GANX) Stock Analysis

NASDAQHealthcareBiotechnology

$1.78+0.28%

1-year price historyRange $1.58 – $4.18

52-week range$1.78

$1.53$4.34

What Gain Therapeutics does

Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins. The company primarily directs its efforts towards rare genetic disorders and neurological ailments. It employs its unique Site-Directed Enzyme Enhancement Therapy (SEE-Tx) platform to pinpoint specific allosteric sites on malformed proteins. Subsequently, Gain Therapeutics identifies proprietary small molecules designed to bind to these locations, thereby restoring correct protein conformation and alleviating the disease. Their current development pipeline includes several structurally targeted allosteric regulator candidates aimed at combating a range of diseases, such as Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1. Established in 2017, the company is headquartered in Bethesda, Maryland.

Key metrics

Market cap

$75.71M

P/E (TTM)

-3.55

EPS (TTM)

$-0.50

Beta

0.20

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.84

200-day avg

$2.18

52-week high

$4.34

52-week low

$1.53

CEO

Gene Mack

ETFs linked to GANX

Broad-market and Healthcare sector ETFs an investor holding Gain Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how GANX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GANX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Gain Therapeutics?: Gain Therapeutics trades under the ticker GANX on NASDAQ.
Which exchange is GANX listed on?: GANX is listed on NASDAQ.
What sector does Gain Therapeutics operate in?: Gain Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GANX in a portfolio?: PortView shows GANX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.